Cargando…
Efficacy of sifalimumab for treatment of skin injury caused by systemic lupus erythematosus
BACKGROUND: This study aims to provide the best possible evidence-based information on the efficacy and safety of sifalimumab for treatment of skin injury (SI) caused by systemic lupus erythematosus (SLE). METHODS: In this study, electronic databases of MEDLINE, EMBASE, Cochrane Library, PsycINFO, C...
Autores principales: | Huo, Ai-xin, Chen, Wen-hui, Liu, Yu-hong, Gao, Peng, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824784/ https://www.ncbi.nlm.nih.gov/pubmed/31651869 http://dx.doi.org/10.1097/MD.0000000000017607 |
Ejemplares similares
-
Population Pharmacokinetics of Sifalimumab, an Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus
por: Narwal, Rajesh, et al.
Publicado: (2013) -
PADI4 and IL-33 gene polymorphisms associated with differential susceptibility to juvenile-onset systemic lupus erythematosus and juvenile idiopathic arthritis in Chinese children
por: Zhou, Yu, et al.
Publicado: (2022) -
Efficacy of clomifene citrate combined Bushen Culuan Decoction for the treatment of infertility caused by polycystic ovary syndrome: A protocol of systematic review
por: Feng, Jing, et al.
Publicado: (2020) -
Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease: A protocol of systematic review
por: Li, Wei-hua, et al.
Publicado: (2020) -
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
por: Khamashta, Munther, et al.
Publicado: (2016)